Calibr-Skaggs awarded $5.1M by NIH to develop long-acting hepatitis B virus therapy
June 16, 2026
June 16, 2026
LA JOLLA, California, June 16 [Category: Environment] -- The Scripps Research Institute posted the following news:
* * *
Calibr-Skaggs awarded $5.1M by NIH to develop long-acting hepatitis B virus therapy
*
A new program aims to replace a daily HBV drug with once-monthly-or even quarterly-injections for people managing both HIV and HBV.
Of the 1.2 million people living with HIV in the United States, approximately 10% are also infec . . .
* * *
Calibr-Skaggs awarded $5.1M by NIH to develop long-acting hepatitis B virus therapy
*
A new program aims to replace a daily HBV drug with once-monthly-or even quarterly-injections for people managing both HIV and HBV.
Of the 1.2 million people living with HIV in the United States, approximately 10% are also infec . . .